Whole-genome sequencing of quartet families with autism spectrum disorder

Nature Medicine

Volumn 21, Issue 2, 2015, Pages 185-191

  Yuen, Ryan K C ^a   Thiruvahindrapuram, Bhooma ^a   Merico, Daniele ^a   Walker, Susan ^a   Tammimies, Kristiina ^a,b   Hoang, Ny ^c   Chrysler, Christina ^d   Nalpathamkalam, Thomas ^a   Pellecchia, Giovanna ^a   Liu, Yi ^a,e   Gazzellone, Matthew J ^a   D'Abate, Lia ^a   Deneault, Eric ^a   Howe, Jennifer L ^a   Liu, Richard S C ^a   Thompson, Ann ^d   Zarrei, Mehdi ^a   Uddin, Mohammed ^a   Marshall, Christian R ^a,c   Ring, Robert H ^f   Zwaigenbaum, Lonnie ^g   Ray, Peter N ^c   Weksberg, Rosanna ^c   Carter, Melissa T ^c   Fernandez, Bridget A ^h,i   Roberts, Wendy ^c   Szatmari, Peter ^c,j,k   Scherer, Stephen W ^a,l   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e QILU CHILDREN S HOSPITAL OF SHANDONG UNIVERSITY   (China)

^f Autism Speaks Inc   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁱ Eastern Health Canada   (Canada)

^j CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; CHILD; CLINICAL FEATURE; DIAGNOSTIC VALUE; FAMILY; FEMALE; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; PARENT; PHENOTYPE; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; ADULT; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS;

ADULT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PARENTS; SEQUENCE ANALYSIS, DNA; SIBLINGS;

EID: 84922628604     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3792     Document Type: Article

References (50)

1. Ronald, A. & Hoekstra, R.A. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. Med. Genet. B Neuropsychiatr. Genet. 156B, 255-274 (2011).
2. Sandin, S. et al. The familial risk of autism. J. Am. Med. Assoc. 311, 1770-1777 (2014).
3. Ozonoff, S. et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 128, e488-e495 (2011).
4. Toma, C. et al. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol. Psychiatry 19, 784-790 (2014).
5. Zhao, X. et al. A unified genetic theory for sporadic and inherited autism. Proc. Natl. Acad. Sci. USA 104, 12831-12836 (2007).
6. Constantino, J.N. et al. Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD. Mol. Psychiatry 18, 137-138 (2013).
7. De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014).
8. Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014).
9. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007).
10. Marshall, C.R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477-488 (2008).
11. Pinto, D. et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94, 677-694 (2014).
12. Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368-372 (2010).
13. Devlin, B. & Scherer, S.W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 22, 229-237 (2012).
14. Betancur, C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 1380, 42-77 (2011).
15. Xiong, H.Y. et al. The splicing code reveals new insights into the genetic determinants of disease. Science (in press) (2014).
16. Bae, B.I. et al. Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning. Science 343, 764-768 (2014).
17. Noor, A. et al. Disruption at the PTCHD1locus on Xp22.11 in autism spectrum disorder and intellectual disability. Sci. Transl. Med. 2, 49ra68 (2010).
18. Kerin, T. et al. A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci. Transl. Med. 4, 128ra140 (2012).
19. Ghahramani Seno, M.M. et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res. 1380, 85-97 (2011).
20. Autism Genome Project Consortium. et al. Mapping autism-risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319-328 (2007).
21. Jiang, Y.H. et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 93, 249-263 (2013).
22. Gilissen, C. et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344-347 (2014).
23. Risch, N. et al. A genomic screen of autism: evidence for a multilocus etiology. Am. J. Hum. Genet. 65, 493-507 (1999).
24. Carnevali, P. et al. Computational techniques for human genome resequencing using mated gapped reads. J. Comput. Biol. 19, 279-292 (2012).
25. Pang, A.W., Macdonald, J.R., Yuen, R.K., Hayes, V.M. & Scherer, S.W. Performance of high-throughput sequencing for the discovery of genetic variation across the complete size spectrum. G3 4, 63-65 (2014).
26. 1000 Genomes Project Consortium. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
27. Exome Variant Server. (NHLBI GO Exome Sequencing Project (ESP), Seattle, WA) ?http://evs.gs.washington.edu/EVS/?.
28. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-Assembling DNA nanoarrays. Science 327, 78-81 (2010).
29. Wellderly Study. ftp://stsi-ftp.sdsc.edu/pub/wellderly/.
30. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
31. Veltman, J.A. & Brunner, H.G. De novo mutations in human genetic disease. Nat. Rev. Genet. 13, 565-575 (2012).
32. Keinan, A. & Clark, A.G. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 336, 740-743 (2012).
33. Tennessen, J.A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64-69 (2012).
34. Piton, A. et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol. Psychiatry 16, 867-880 (2011).
35. Lim, E.T. et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77, 235-242 (2013).
36. O'Roak, B.J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250 (2012).
37. Anney, R. et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 21, 4781-4792 (2012).
38. Richards, C.S. et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet. Med. 10, 294-300 (2008).
39. Campbell, I.M. et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am. J. Hum. Genet. 95, 173-182 (2014).
40. Campbell, I.M. et al. Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A. Genet. Med. 14, 868-876 (2012).
41. Kishino, T., Lalande, M. & Wagstaff, J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73 (1997).
42. Bochukova, E. et al. A mutation in the thyroid hormone receptor alpha gene. N. Engl. J. Med. 366, 243-249 (2012).
43. van Mullem, A. et al. Clinical phenotype and mutant TR?1. N. Engl. J. Med. 366, 1451-1453 (2012).
44. Moran, C. et al. Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)?1 and TR?2: clinical, biochemical, and genetic analyses of three related patients. Lancet Diabetes Endocrinol. 2, 619-626 (2014).
45. Smith, R.J.H., Shearer, A.E., Hildebrand, M.S. & Van Camp, G. Deafness and Hereditary Hearing Loss Overview. in GeneReviews (eds. Pagon, R.A., et al.) (University of Washington, 1993).
46. Rosenhall, U., Nordin, V., Sandstrom, M., Ahlsen, G. & Gillberg, C. Autism and hearing loss. J. Autism Dev. Disord. 29, 349-357 (1999).
47. Buxbaum, J.D. et al. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 76, 1052-1056 (2012).
48. Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747 (2014).
49. Numata, S. et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am. J. Hum. Genet. 90, 260-272 (2012).
50. Weiss, L.A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667-675 (2008).